
Hikma Integrative Healthcare Introduces EXOMIND®, a Drug-Free, FDA-Cleared Treatment for Depression
Hikma Integrative Healthcare has launched EXOMIND®, an FDA-cleared, drug-free treatment for Major Depressive Disorder (MDD) that utilizes innovative ExoTMS® technology. This non-invasive therapy targets specific brain areas to enhance emotional regulation and cognitive function, offering new hope for patients who have not found relief with traditional medications. Clinical trials indicate that 83% of participants felt less depressed three months after treatment, with minimal discomfort reported during sessions. Dr. Aishah Suleiman emphasizes the importance of accessible mental health solutions, stating that EXOMIND represents a significant advancement in empowering patients to manage their mental wellness effectively.

Commenti